Literature DB >> 9070703

Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels.

J Farhi1, R Homburg, A Ferber, R Orvieto, Z Ben Rafael.   

Abstract

The most important aspect of diminished ovarian reserve is the associated decline in reproductive potential. Assessment of ovarian reserve is mainly based on measurement of early follicular phase follicle stimulating hormone (FSH) concentration. The objective of this study was to report the identification of a group of 12 infertile women initially diagnosed as having unexplained or anovulatory infertility, who had a normal baseline hormonal profile and did not respond to repeated ovarian stimulation with gonadotrophins. All developed ovarian failure within a relatively short time span. Non-response to ovarian stimulation was defined by failure to achieve development of follicles >12 mm and failure to raise oestradiol concentration >350 pmol/l in two successive cycles of human menopausal gonadotrophin (HMG) doses of up to five ampoules per day for 5-8 days. Within a mean of 9 months following the failed attempts of ovarian stimulation the mean day 3 FSH concentrations rose from 5.4 +/- 2.7 IU/l to 53.5 +/- 19.7 IU/l. In these patients, day 3 FSH concentration failed to indicate the low ovarian reserve manifested only by lack of clinical response to treatment with gonadotrophins which was the first sign of impending ovarian failure. We conclude that women with normal early follicular phase serum FSH concentrations who do not respond to ovarian stimulation by HMG are at risk of developing ovarian failure within several months.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070703     DOI: 10.1093/humrep/12.2.241

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  12 in total

1.  Mean ovarian diameter (MOD) as a predictor of poor ovarian response.

Authors:  Iavor K Vladimirov; Desislava M Tacheva; Krassimir B Kalinov
Journal:  J Assist Reprod Genet       Date:  2004-03       Impact factor: 3.412

2.  Anti-mullerian hormone as a predictive marker for the selection of women for oocyte in vitro maturation treatment.

Authors:  Rubens Fadini; Ruggero Comi; Mario Mignini Renzini; Giovanni Coticchio; Marilena Crippa; Elena De Ponti; Mariabeatrice Dal Canto
Journal:  J Assist Reprod Genet       Date:  2011-06-15       Impact factor: 3.412

3.  Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET?

Authors:  E al-Mizyen; L Sabatini; A M Lower; C M Wilson; T al-Shawaf; J G Grudzinskas
Journal:  J Assist Reprod Genet       Date:  2000-03       Impact factor: 3.412

4.  Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome.

Authors:  F Fábregues; J Balasch; M Creus; F Carmona; B Puerto; L Quintó; R Casamitjana; J A Vanrell
Journal:  J Assist Reprod Genet       Date:  2000-01       Impact factor: 3.412

Review 5.  Ovarian autoimmune disease: clinical concepts and animal models.

Authors:  Bryce D Warren; William K Kinsey; Lynda K McGinnis; Lane K Christenson; Susmita Jasti; Anne M Stevens; Brian K Petroff; Margaret G Petroff
Journal:  Cell Mol Immunol       Date:  2014-10-20       Impact factor: 11.530

6.  Demographic characteristics and clinical profile of poor responders in IVF / ICSI: A comparative study.

Authors:  Nabaneeta Padhy; Shalu Gupta; Asmita Mahla; M Latha; Thangam Varma
Journal:  J Hum Reprod Sci       Date:  2010-05

7.  Dynamic measurements of serum inhibin B and estradiol: a predictive evaluation of ovarian response to gonadotrophin stimulation in the early stage of IVF treatment.

Authors:  Ming-fang Miao; He-feng Huang
Journal:  J Zhejiang Univ Sci B       Date:  2009-01       Impact factor: 3.066

8.  Blood cell mitochondrial DNA content and premature ovarian aging.

Authors:  Marco Bonomi; Edgardo Somigliana; Chiara Cacciatore; Marta Busnelli; Raffaella Rossetti; Silvia Bonetti; Alessio Paffoni; Daniela Mari; Guido Ragni; Luca Persani
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

9.  Contemporary genetic technologies and female reproduction.

Authors:  B C J M Fauser; K Diedrich; P Bouchard; F Domínguez; M Matzuk; S Franks; S Hamamah; C Simón; P Devroey; D Ezcurra; C M Howles
Journal:  Hum Reprod Update       Date:  2011-09-06       Impact factor: 15.610

Review 10.  Biological versus chronological ovarian age: implications for assisted reproductive technology.

Authors:  Carlo Alviggi; Peter Humaidan; Colin M Howles; Donald Tredway; Stephen G Hillier
Journal:  Reprod Biol Endocrinol       Date:  2009-09-22       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.